Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients - Concepedia

Concepedia

Publication | Closed Access

Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients

34

Citations

24

References

2001

Year

Adrian D. Griffin, Andrew Perry, Douglas Fleming

PharmacoEconomics

VaccinationPreventive MedicineCost-effectiveness AnalysisInhaled ZanamivirRespiratory InfectionInfectious Respiratory DiseasePharmacoeconomicsMedicineEpidemiologyInfluenza AInfluenza Vaccines

References

	Year	Citations

Page 1